YU66199A - Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju - Google Patents

Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju

Info

Publication number
YU66199A
YU66199A YU66199A YU66199A YU66199A YU 66199 A YU66199 A YU 66199A YU 66199 A YU66199 A YU 66199A YU 66199 A YU66199 A YU 66199A YU 66199 A YU66199 A YU 66199A
Authority
YU
Yugoslavia
Prior art keywords
projection mammography
contrast agents
intravenous
mammography
devices
Prior art date
Application number
YU66199A
Other languages
English (en)
Inventor
Ulrich Speck
Brenndorff Irtel Von
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU66199A publication Critical patent/YU66199A/sh
Publication of RS49734B publication Critical patent/RS49734B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
  • Liquid Crystal (AREA)
  • Holo Graphy (AREA)

Abstract

Pronalazak se odnosi na primenu intravenoznih kontrastnih sredstava za projekcionu mamografiju kao i nove uredjaje za projekcionu mamografiju.Stoga se pronalazak odnosi na primenu intravenoznih kontrastnih sredstava za izradu dijagnostičkog sredstva za projekcionu mamografiju. Dodatnim intravenoznim davanjem kontrastnog sredstva dostiže projekciona mamografija uporedljivu osetljivost sa najmodernijim postupcima kao magnetno rezonantnom tomografijom (MRT) pri jasno mnogostranijoj mogućnosti upotrebe i uz izbegavanje troškova MRT. Novi postupak može jednostavno da se izvodi i bez naročitih opterećenja pacijentkinja i daje bitno poboljšanje a) osteljivosti za dokaz fokalnih lezija u grudima i b) dodatne informacije o svojstvu prethodno otkrivenih lezija.[The invention relates to the use of intravenous contrast agents for projection mammography and novel devices for carrying out projection mammography. The invention therefore relates to the use of intravenous contrast agents for producing a diagnostic medium for projection mammography. With the additional intravenous administration of contrast agent, projection mammography attains a sensitivity comparable to the most modern methods, such as magnetic resonance tomography (MRT) while having a wider range of applications and avoiding the cost of MRT. This novel method is simple and can be carried out without special inconvenience for the patients. It a) considerably improves sensitivity for demonstrating focal lesions in the mammae and b) provides additional information on the character of previously detected lesions.
YUP-661/99A 1997-06-20 1998-06-19 Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju RS49734B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97250190A EP0885616A1 (de) 1997-06-20 1997-06-20 Verwendung von intravenösen Kontrastmitteln sowie Vorrichtungen für die Projektionsmammographie

Publications (2)

Publication Number Publication Date
YU66199A true YU66199A (sh) 2002-10-18
RS49734B RS49734B (sr) 2008-04-04

Family

ID=8229158

Family Applications (1)

Application Number Title Priority Date Filing Date
YU66299A YU66299A (sh) 1997-06-20 1998-06-19 Uredaji za projekcionu mamografiju

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU66299A YU66299A (sh) 1997-06-20 1998-06-19 Uredaji za projekcionu mamografiju

Country Status (28)

Country Link
US (2) US20020031475A1 (sh)
EP (3) EP0885616A1 (sh)
JP (3) JP4664449B2 (sh)
KR (2) KR100582980B1 (sh)
CN (2) CN1263449A (sh)
AT (1) ATE229820T1 (sh)
AU (2) AU747033B2 (sh)
BG (2) BG104018A (sh)
BR (2) BR9810215A (sh)
CA (2) CA2294187A1 (sh)
CZ (1) CZ298462B6 (sh)
DE (1) DE59806743D1 (sh)
DK (1) DK0994729T3 (sh)
HK (1) HK1029759A1 (sh)
HU (2) HUP0003096A1 (sh)
IL (2) IL133573A0 (sh)
NO (2) NO996292L (sh)
NZ (2) NZ501603A (sh)
PL (2) PL337286A1 (sh)
RS (1) RS49734B (sh)
RU (1) RU2194533C2 (sh)
SI (2) SI20148A (sh)
SK (2) SK181199A3 (sh)
TR (2) TR199903144T2 (sh)
UA (1) UA71895C2 (sh)
WO (2) WO1998058679A1 (sh)
YU (1) YU66299A (sh)
ZA (1) ZA985395B (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10118792B4 (de) * 2001-04-05 2005-12-22 Schering Ag Anordnung zur Aufnahme von Projektionsmammogrammen und Verwendung der Anordnung für die Projektionsmammographie
FR2823969B1 (fr) * 2001-04-30 2003-12-26 Ge Med Sys Global Tech Co Llc Procede de prelevement d'un tissu au cours d'un examen par rayons x et dispositif de mise en oeuvre
DE102005033235A1 (de) * 2005-07-15 2007-01-18 Siemens Ag Verfahren zur Visualisierung eines vaskulären Einsatzstücks
US20080167552A1 (en) * 2007-01-04 2008-07-10 General Electric Company System and method of generating an image of a contrast agent injected into an imaged subject
FR2927719B1 (fr) * 2008-02-19 2010-03-26 Gen Electric Procede de traitement d'images obtenues par tomosynthese et dispositif associe
US8315449B2 (en) * 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
JP2012055549A (ja) * 2010-09-10 2012-03-22 Fujifilm Corp バイオプシ用ファントム
FR2967888B1 (fr) * 2010-11-26 2012-12-21 Gen Electric Procede de galactographie et mammographe pour l'execution dudit procede
US9651138B2 (en) 2011-09-30 2017-05-16 Mtd Products Inc. Speed control assembly for a self-propelled walk-behind lawn mower
DE102012217301B4 (de) 2012-09-25 2021-10-14 Bayer Pharma Aktiengesellschaft Kombination aus Kontrastmittel und Mammographie-CT-System mit vorgegebenem Energiebereich und Verfahren zur Erzeugung tomographischer Mammographie-CT-Aufnahmen durch diese Kombination
EA036245B1 (ru) * 2017-10-26 2020-10-16 Казахский научно-исследовательский институт онкологии и радиологии Способ диагностики рака молочной железы
EP3498306A1 (de) * 2017-12-16 2019-06-19 Bionorica SE Extrakte aus vitex agnus castus zur behandlung und diagnose von brustkrebs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
FR2541272A1 (fr) * 1983-02-23 1984-08-24 Guerbet Sa Composes bromes et produits opacifiants en contenant
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上（およびスペクトルシフト）のためのポリキレ−ト剤
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5844965A (en) * 1989-11-24 1998-12-01 Thomas Jefferson University Method and apparatus for using film density measurements of a radiograph to monitor the reproducibility of X-ray exposure parameters of a mammography unit
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4417628C1 (de) * 1994-05-19 1995-09-28 Siemens Ag Verfahren zur adaptiven Rauschverminderung für digitale Bildsequenzen
CZ166797A3 (en) * 1994-11-30 1997-11-12 Schering Ag Application of metal complexes as liver and gallbladder x-ray diagnostic agents
US5756066A (en) * 1995-06-07 1998-05-26 Schering Aktiengesellschaft Iodine-containing peptides
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
US6009342A (en) * 1997-02-28 1999-12-28 The Regents Of The University Of California Imaging method for the grading of tumors

Also Published As

Publication number Publication date
NO996291D0 (no) 1999-12-17
HUP0003097A3 (en) 2003-07-28
ZA985395B (en) 1999-04-07
JP2002505679A (ja) 2002-02-19
KR20010013980A (ko) 2001-02-26
CA2294502A1 (en) 1998-12-30
PL337286A1 (en) 2000-08-14
HU225522B1 (en) 2007-01-29
NO996291L (no) 1999-12-17
AU8627198A (en) 1999-01-04
IL133574A0 (en) 2001-04-30
US20050008574A1 (en) 2005-01-13
EP0994729A1 (de) 2000-04-26
RU2194533C2 (ru) 2002-12-20
CA2294502C (en) 2009-03-31
SI20152A (sl) 2000-08-31
PL337287A1 (en) 2000-08-14
CN1263474A (zh) 2000-08-16
NZ501602A (en) 2002-02-01
EP0994729B1 (de) 2002-12-18
CN1212862C (zh) 2005-08-03
SK181199A3 (en) 2000-07-11
BG104018A (en) 2000-05-31
DK0994729T3 (da) 2003-03-10
BG64895B1 (bg) 2006-08-31
JP2011012074A (ja) 2011-01-20
CA2294187A1 (en) 1998-12-30
NO996292D0 (no) 1999-12-17
IL133573A0 (en) 2001-04-30
DE59806743D1 (de) 2003-01-30
WO1998058679A1 (de) 1998-12-30
CN1263449A (zh) 2000-08-16
JP2002504843A (ja) 2002-02-12
CZ298462B6 (cs) 2007-10-10
BG104017A (en) 2000-05-31
SI20148A (sl) 2000-08-31
EP0885616A1 (de) 1998-12-23
PL191807B1 (pl) 2006-07-31
BR9810215A (pt) 2000-08-08
KR20010013979A (ko) 2001-02-26
SK282716B6 (sk) 2002-11-06
RS49734B (sr) 2008-04-04
NO315638B1 (no) 2003-10-06
NO996292L (no) 1999-12-17
BR9810205A (pt) 2000-08-08
US20020031475A1 (en) 2002-03-14
CZ460999A3 (cs) 2000-04-12
TR199903144T2 (xx) 2000-08-21
HUP0003096A1 (hu) 2001-01-29
IL133574A (en) 2004-03-28
YU66299A (sh) 2002-09-19
AU747033B2 (en) 2002-05-09
WO1998058585A1 (de) 1998-12-30
SK171299A3 (en) 2000-05-16
NZ501603A (en) 2002-02-01
JP4664449B2 (ja) 2011-04-06
UA71895C2 (en) 2005-01-17
KR100582980B1 (ko) 2006-05-24
HK1029759A1 (en) 2001-04-12
HUP0003097A1 (hu) 2001-01-29
ATE229820T1 (de) 2003-01-15
EP0991356A1 (de) 2000-04-12
AU8337998A (en) 1999-01-04
TR199903140T2 (xx) 2000-05-22

Similar Documents

Publication Publication Date Title
HK1050898A1 (en) Intermediate used for manufacturing cascade polymer complexes.
FI854488A0 (fi) Kontrastmedel.
YU66199A (sh) Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju
AU1122401A (en) Evaluating disease progression using magnetic resonance imaging
ES2138970T3 (es) Medios de contraste.
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
EP1640737A3 (en) Evaluating disease progression using magnetic resonance imaging
Belli et al. Low-field open-MRI study of TMJ (temporomandibular joint)
Sconfienza et al. Magnetic resonance imaging of the elbow
UA10349A (uk) Спосіб радіоhуклідhої діагhостики захворюваhь щітовидної залози